(NQ: )

N/A UNCHANGED

Last Price Updated: Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	-
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

Analysts Predict 11% Gains Ahead For RORO

June 28, 2016

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...

Arrowhead Reports Fiscal 2016 Second Quarter Results

May 10, 2016

Arrowhead Pharmaceuticals reports fiscal 2016 second quarter earnings and holds a conference call to discuss results

Performance

More News

Arbutus Biopharma Taken Off Of Chardan's Sell List

June 16, 2016

Arrowhead Pharmaceuticals’ Preclinical Candidate ARC-LPA Achieves 98% Knockdown and Long Duration of Effect after Subcutaneous Administration

May 06, 2016

11 Biotechnology Stocks to Buy Now

June 06, 2016

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Second Quarter Results

May 03, 2016

5 Reasons Arrowhead Pharma Is A Hepatitis B Leader

May 19, 2016

Arrowhead Research Shares Up 20.5% Since SmarTrend's Buy Recommendation (ARWR)

May 16, 2016

Arrowhead Says ARC-LPA Achieved 98% Knockdown, Long Duration of Effect After Subcutaneous Admin

May 06, 2016

Uptrend Call Working As Arrowhead Research Stock Rises 33.8% (ARWR)

May 09, 2016

34.3% Return Seen to Date on SmarTrend Arrowhead Research Call (ARWR)

April 29, 2016

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.